Data on Hyperglycemia Described by Researchers at Department of Internal Medicine (Development of Nonketotic Hyperglycemia Requiring High-Dose Insulin After Supratherapeutic Amlodipine Ingestion).

Researchers at the Department of Internal Medicine have published a study on hyperglycemia caused by an overdose of amlodipine, a calcium channel blocker. The study describes a 74-year-old man who experienced toxicity from consuming 88 tablets of amlodipine, leading to hyperglycemia and requiring high-dose insulin therapy. The research concludes that high-dose insulin euglycemic therapy was effective in treating amlodipine overdose and recommends considering this approach in similar cases. The study provides valuable insights into the management of hyperglycemia resulting from calcium channel blocker toxicity. [Extracted from the article]